%0
Generic
%T
First-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from 2000 patients treated in the multicentre AVANTI study
%A Müller, Volkmar
%A Ruhnke, Markus
%A Hoffmann, Oliver
%A Grafe, Andrea
%A Tomé, Oliver
%A Fett, Werner
%A Bruch, Harald-Robert
%A Sommer-Joos, Ann-Katrin
%A Schneeweiss, Andreas
%I Elsevier BV
%@ 0960-9776
%K General Medicine
%K Surgery
%D 2021
%C Elsevier BV
%U http://slubdd.de/katalog?TN_libero_mab2